Comparison of the pharmacokinetics, safety, and immunogenicity of MSB11022, a biosimilar of adalimumab, with Humira® in healthy subjects
Hyland, Elizabeth, Mant, Tim, Vlachos, Pantelis, Attkins, Neil, Ullmann, Martin, Roy, Sanjeev, Wagner, VolkerМова:
english
Журнал:
British Journal of Clinical Pharmacology
DOI:
10.1111/bcp.13039
Date:
June, 2016
Файл:
PDF, 1.05 MB
english, 2016
File converter
Більше результатів пошуку
More benefits 
